Shares of Chinese pharmaceutical companies plunged Tuesday morning on Chinese bourses, continuing a slide that began in the face of competition from Pfizer’s COVID-19 drug Paxlovid earlier this month.
Shares of Shijiazhuang Yiling Pharmaceutical 002603,
China Meheco Group Co. 600056,
China Meheco signed an agreement to supply Pfizer’s COVID-19 treatment Paxlovid in China in mid-December, as the country has pivoted away from its “zero COVID” policy and allowed a massive outbreak to spread across the country over the past several weeks.
